ArticleExperimental and therapeutic medicine2021

Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19.

Meng-En Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.